For help with your stockholder account or information about Merck stock or dividends, call us toll-free at 800-522-9114.
Annual Meeting
The Annual Meeting of Stockholders will be held at 2 p.m., ET, on Tuesday, April 27, 2004, at the Edward Nash Theatre at Raritan Valley Community College, Route 28 and Lamington Road, North Branch, New Jersey.
Stock Trading Information
Merck stock is listed on the New York Stock Exchange (ticker symbol: MRK), the Philadelphia Stock Exchange and the Paris Stock Exchange.
Direct Purchase of Merck Stock
You can purchase shares directly from the Company through the Merck Stock Investment Plan. Shares also may be purchased by automatic investment each month. Call 800-522-9114, or write to:
Merck Stockholder Services, WS3AB-40
Merck & Co., Inc.
One Merck Drive, P.O. Box 100
Whitehouse Station, NJ 08889-0100
Dividend Reinvestment Plan
Your dividends (all or part) can be automatically reinvested to purchase additional Merck shares. Call 800-522-9114.
Stockholder Services
Call Monday through Friday, 8 a.m. to 8 p.m., ET, with questions on stock-related matters, including verification of your holdings, to change your address or to report lost or missing dividends. Call 800-522-9114, or write to:
Merck Stockholder Services, WS3AB-40
Merck & Co., Inc.
One Merck Drive, P.O. Box 100
Whitehouse Station, NJ 08889-0100
For Changes or Lost Stock Certificates
If you want to transfer your stock, change ownership or if you have lost your stock certificates, call 800-522-9114, or write to:
Merck Shareowner Services
Wells Fargo Bank, N.A.
161 N. Concord Exchange
South St. Paul, MN 55075-1139
Independent Auditors
Independent auditors for Merck can be reached at:
PricewaterhouseCoopers LLP
400 Campus Drive
Florham Park, NJ 07932
973-236-4000
News on Call
You can access Merck news 24 hours a day, seven days a week. Included are the latest news releases on sales and earnings, dividends, new products and other Merck-related information. Call 800-CALL-MRK (800-225-5675).
Investor Relations
Securities analysts and investment professionals with business-related questions should call the Investor Relations department at 908-423-5881.
Journalists
Call Merck Public Affairs at 908-423-6308.
Write for Information
If you want a copy of one of the following, write to:
Public Affairs, WS1A-40
Merck & Co., Inc.
One Merck Drive, P.O. Box 100
Whitehouse Station, NJ 08889-0100
- Merck's 2003 Form 10-K Annual Report, as filed with the Securities and Exchange Commission;
- Report on Merck Corporate Responsibility (available at www.merck.com);
- Report on Diversity at Merck (available at www.merck.com);
- Policies of the Board–a statement of Merck governance principles (available at www.merck.com);
- Merck Board Committee Charters–Audit, Compensation and Benefits, and Committee on Corporate Governance (available at www.merck.com);
- Merck Code of Conduct–Our Values and Standards (available at www.merck.com).
Merck on the Internet
Our home page is located at www.merck.com. This Web address is provided for convenience only and materials therein are not incorporated by reference.
Trademarks
All product or service marks appearing in type form different from that of the surrounding text are trademarks or service marks owned by or licensed to Merck & Co., Inc., its subsidiaries or affiliates. Cozaar and Hyzaar are registered trademarks of E.I. du Pont de Nemours and Company, Wilmington, Delaware, USA. Zetia and Vytorin are trademarks owned by an entity of the Merck/Schering-Plough Pharmaceuticals partnership. Claritin is a trademark of Schering Corporation. Prilosec and Nexium are trademarks of the AstraZeneca group. The U.S. trademarks for Vasotec and Vaseretic are owned by Biovail Laboratories Incorporated. The U.S. trademark for Aggrastat is owned by Guilford Pharmaceuticals Inc.
